Table 3:

Summary of adverse effects (number of persons with worsened adverse effect from baseline | number of persons with improved adverse effect from baseline)

ADVERSE EFFECT CHECKLIST	WEEK 3 WORSENED | IMPROVED FROM BASELINE
	Cyproheptadine	Placebo
DRY MOUTH	14 | 1	5 | 7
LOW ENERGY	12 | 6	7 | 9
LOW MOTIVATION	11 | 4	4 | 0
WEIGHT GAIN	8 | 4	3 | 8
CONSTIPATION	9 | 3	4 | 5
RESTLESS OR JITTERY	8 | 4	4 | 2
LIGHTHEADEDNESS	8 | 6	5 | 5
FREQUENT URINATION	8 | 8	5 | 11
SLOWNESS/TROUBLE GETTING MOVING	8 | 10	3 | 14
SLEEP PROBLEMS	7 | 12	4 | 6
DROOLING	5 | 4	5 | 3
SHAKING	4 | 3	0 | 8
ANXIETY	4 | 10	1 | 4
NAUSEA	3 | 0	1 | 0
MEMORY PROBLEMS	3 | 5	1 | 10
WEIGHT LOSS	3 | 6	1 | 8
DIFFICULTY URINATING	2 | 2	3 | 1
HEADACHES	2 | 2	2 | 6
DIFICULTY CONCENTRATING	2 | 6	4 | 6
BLURRED VISION	2 | 11	2 | 6
VOMITING	1 | 1	0 | 0
CHANGES IN BREASTS	1 | 1	0 | 0
PROBLEMS WITTH SEXUAL FUNCTION	1 | 2	0 | 2
MUSCLE STIFFNESS	1 | 15	2 | 14
CHANGES IN MENSES	0 | 0	0 | 1
HEART FLUTTERS	0 | 1	1 | 0
FALLS	0 | 6	0 | 1